ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,179.68
-0.55%
Dow Jones
39,164.06
0.09%
Gold vs US Dollar
2,327.67
0.00%
Brent Oil
85.415
0.00%
Bitcoin
61,573.63
-0.06%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Principia Biopharma Inc (PRNB)

  7. Principia Biopharma Inc (PRNB) News

Principia Biopharma (PRNB)

Principia Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRNB
DateTimeSourceHeadlineSymbolCompany
16/02/202120:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRNBPrincipia Biopharma Inc
24/11/202013:00GlobeNewswire Inc.Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for RilzabrutinibNASDAQ:PRNBPrincipia Biopharma Inc
08/10/202012:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PRNBPrincipia Biopharma Inc
01/10/202011:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202022:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202022:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202022:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202022:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202014:20Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202014:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202014:16Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202014:12Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202013:49Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202013:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202011:35Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRNBPrincipia Biopharma Inc
28/09/202011:31Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRNBPrincipia Biopharma Inc
22/09/202011:44Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PRNBPrincipia Biopharma Inc
22/09/202011:32Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRNBPrincipia Biopharma Inc
17/09/202013:01GlobeNewswire Inc.Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related DiseaseNASDAQ:PRNBPrincipia Biopharma Inc
14/09/202021:34Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PRNBPrincipia Biopharma Inc
10/09/202015:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRNBPrincipia Biopharma Inc
10/09/202013:00GlobeNewswire Inc.Neoleukin Therapeutics Announces Appointment of Martin Babler to Board of DirectorsNASDAQ:PRNBPrincipia Biopharma Inc
28/08/202006:44Dow Jones NewsSanofi to Launch Tender Offer for Principia AcquisitionNASDAQ:PRNBPrincipia Biopharma Inc
25/08/202017:33Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PRNBPrincipia Biopharma Inc
21/08/202011:01Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PRNBPrincipia Biopharma Inc
20/08/202021:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRNBPrincipia Biopharma Inc
20/08/202021:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PRNBPrincipia Biopharma Inc
19/08/202018:50Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRNBPrincipia Biopharma Inc
18/08/202011:01Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PRNBPrincipia Biopharma Inc
18/08/202008:02Dow Jones NewsSanofi Buys MS-Drug Development Partner -- WSJNASDAQ:PRNBPrincipia Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:PRNB

Your Recent History

ASX
HUM
Humm
USOTC
BAYP
Bayport (CE)
COIN
INDEXETH
Index
EU
9647T
9647T
GATE
LKRUSDT
Polkalokr
COIN
BBTGBP
BitBoost
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved